• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Voice Preservation

Making Our Voices Heard

Speech is a key part of a person’s identity. Voice matters to personal identity and expression, and connection with family and friends. The majority of people living with ALS/MND are eventually robbed of this fundamental part of their humanity.

This can be overcome using voice preservation technologies, but our research shows this is not equitably accessible. The Alliance seeks to provide universal access to technology to improve the quality of life of people living with ALS/MND. The ideal for every individual living with ALS/MND worldwide is to have the right to access voice preservation upon diagnosis.

The Voice Preservation Project

The Alliance, through a collaboration between Hospital Universitario Nacional de Colombia (HUN) and the Asociación Colombiana de ELA (ACELA), has launched a pilot project to deliver voice preservation technology to people living with ALS/MND in Colombia. This will serve as the basis on which future plans will be made on how best to scale to reach more people around the world.

If you would like to join us in expanding our reach to more people, please donate. We deeply appreciate your support.

Watch this video to find out more from the Alliance and its Information Technology Advisory Council (ITAC).

https://www.als-mnd.org/wp-content/uploads/2023/06/Voice-Preservation-ITAC-Intro.mp4

Watch this video to hear from Orlando Ruiz, founder of ACELA and a person living with ALS/MND, as he emphasizes the devastation of losing your voice. He goes on to explain the potential of voice banking technology to preserve dignity, autonomy and identity, and ensure no one loses their voice to ALS/MND.

 

Keep Up To Date

This project is in development and more details and information are coming soon! If you are interested in learning more, sign up to get periodic updates as the work progresses.

Subscribe

* indicates required
 
 

 

Disclaimer: Voice preservation is not designed, intended or made available for diagnosis, treatment or prevention of diseases or for use as a medical device. It is also not designed or intended to replace or be a substitute for professional medical advice, diagnosis, treatment or judgment.

Primary Sidebar

  • Timmy, Belgium

    Timmy, Belgium

  • Jean Waters, UK

    Jean Waters, UK

  • Purningam Jacob, India

    Purningam Jacob, India

  • Ali Var, Turkey

    Ali Var, Turkey

  • Glen Elison, USA

    Glen Elison, USA

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Irene McCaughey, Australia

    Irene McCaughey, Australia

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Christian Bär, Germany

    Christian Bär, Germany

  • Dick Dayton, USA

    Dick Dayton, USA

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • David Solomon, UK

    David Solomon, UK

  • Lachlan Terry, Australia

    Lachlan Terry, Australia

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • David Bishop, UK

    David Bishop, UK

  • Anna Barrow, UK

    Anna Barrow, UK

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Bruno Leanza Mantegna, Italy

    Bruno Leanza Mantegna, Italy

  • Phil Rossall, UK

    Phil Rossall, UK

  • Alex, Argentina

    Alex, Argentina

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Fayette Underwood, USA

    Fayette Underwood, USA

  • Philip Brindle, England

    Philip Brindle, England

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Debbie Craghill, USA

    Debbie Craghill, USA

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Graham Johnson, Australia

    Graham Johnson, Australia

  • Jack Buzby, USA

    Jack Buzby, USA

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Mike Cels, Canada

    Mike Cels, Canada

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Sally Pauls, USA

    Sally Pauls, USA

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login